Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Becophos Forte
- Development stage
- Unknown
- Lead developer
- TCF Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Becophos Forte is an oral nutritional supplement capsule developed and marketed by TCF Pharmaceuticals. It is formulated as a combination of Vitamin B-complex and Vitamin C (ascorbic acid) to address nutritional deficiencies. The Vitamin B-complex components serve as essential coenzymes in various metabolic pathways, including energy production and red blood cell synthesis, while Vitamin C acts as a potent antioxidant and cofactor for collagen synthesis and immune function. The product is approved and marketed in India for the management of vitamin deficiencies and supportive cellular health.
- Brand names
- Becophos Forte
- Other names
- Vitamin B complex + Vitamin CVitamin B-Complex + Vitamin Cvitamin B complex + ascorbic acid
Beyond the preview
Go deeper on Becophos Forte.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Becophos Forte.